Tirzepatide is a novel medication primarily used for the treatment of type 2 diabetes mellitus (T2DM). It is a synthetic peptide that acts as a dual agonist for two important receptors involved in glucose regulation:

• GIP receptor (glucose-dependent insulinotropic polypeptide receptor)

• GLP-1 receptor (glucagon-like peptide-1 receptor)

What Tirzepatide Does:

• Increases insulin secretion: By activating GIP and GLP-1 receptors, tirzepatide enhances the release of insulin from the pancreas in response to elevated blood glucose levels.

• Lowers blood sugar: It helps reduce blood glucose by promoting insulin release and suppressing glucagon secretion (a hormone that raises blood sugar).

• Supports weight loss: Tirzepatide also slows gastric emptying and reduces appetite, which can contribute to weight loss in patients.

• Adjunct to diet and exercise: It is used alongside lifestyle changes to improve blood sugar control in adults with type 2 diabetes.

Additional Information:

• Tirzepatide is administered via injection.

• It has been approved by regulatory agencies like the FDA for managing type 2 diabetes.

• Some risks include potential thyroid tumors, so monitoring is recommended during treatment.

In summary, tirzepatide is an advanced diabetes medication that improves blood sugar control by targeting two key hormonal pathways, also offering benefits in weight management.